Cargando…

Re-Expression of ERα and AR in Receptor Negative Endocrine Cancers via GSK3 Inhibition

DNA methylation, catalyzed by DNA methyltransferase (DNMT), is a well-characterized epigenetic modification in cancer cells. In particular, promoter hypermethylation of AR and ESR1 results in loss of expression on Androgen Receptor (AR) and Estrogen Receptor (ER), respectively, and is associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Vikas, Joshi, Jayadev, Yeh, I-Ju, Doughman, YongQiu, Blankenberg, Daniel, Wald, David, Montano, Monica M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988137/ https://www.ncbi.nlm.nih.gov/pubmed/35402240 http://dx.doi.org/10.3389/fonc.2022.824594

Ejemplares similares

IL-1-conferred gene expression pattern in ERα(+) BCa and AR(+) PCa cells is intrinsic to ERα(−) BCa and AR(−) PCa cells and promotes cell survival
por: Nawas, Afshan F., et al.
Publicado: (2020)

PDAUG: a Galaxy based toolset for peptide library analysis, visualization, and machine learning modeling
por: Joshi, Jayadev, et al.
Publicado: (2022)

Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression
por: Li, Yuanyuan, et al.
Publicado: (2017)

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study
por: Sgroi, Dennis C., et al.
Publicado: (2022)

ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation
por: Huggins, Rosemary J., et al.
Publicado: (2023)

Hypoxia and ERα Transcriptional Crosstalk Is Associated with Endocrine Resistance in Breast Cancer
por: Jehanno, Charly, et al.
Publicado: (2022)

Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer
por: Pizon, Monika, et al.
Publicado: (2018)

Re-measurement of $^{32}$Ar to test the IMME
por: Kreim, S
Publicado: (2012)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Abrogating endocrine resistance by targeting ERα and PI3K in breast cancer
por: Fox, Emily M., et al.
Publicado: (2012)

Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ERα Expression in Initially ERα+ Breast Cancer Cells
por: Opyrchal, Mateusz, et al.
Publicado: (2014)

GSK-3β-dependent downregulation of γ-taxilin and αNAC merge to regulate ER stress responses
por: Hotokezaka, Y, et al.
Publicado: (2015)

Immunoreactivities of AR, ERα, ERβ and aromatase in the nuptial pad of Chinese brown frog (Rana dybowskii) during pre-hibernation and the breeding period
por: Tang, Zeqi, et al.
Publicado: (2021)

AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance
por: Ng, Angel S.N., et al.
Publicado: (2022)

AR-A 014418 Used against GSK3beta Downregulates Expression of hnRNPA1 and SF2/ASF Splicing Factors
por: Yadav, Ajay K., et al.
Publicado: (2014)

Novel Reporter Alleles of GSK-3α and GSK-3β
por: Barrell, William B., et al.
Publicado: (2012)

Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
por: Li, Yuanyuan, et al.
Publicado: (2013)

Endoplasmic Reticulum (ER) Stress and Endocrine Disorders
por: Ariyasu, Daisuke, et al.
Publicado: (2017)

Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
por: Su, Peng, et al.
Publicado: (2014)

HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland
por: Ogba, Ndiya, et al.
Publicado: (2010)

FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance
por: Yu-Rice, Yi, et al.
Publicado: (2016)

Crosstalk between ERα and Receptor Tyrosine Kinase Signalling and Implications for the Development of Anti-Endocrine Resistance
por: Montaser, Rugaia Z., et al.
Publicado: (2018)

ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
por: Strillacci, Antonio, et al.
Publicado: (2022)

Progression of Mouse Skin Carcinogenesis Is Associated with Increased Erα Levels and Is Repressed by a Dominant Negative Form of Erα
por: Logotheti, Stella, et al.
Publicado: (2012)

Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity
por: Hornig, N. C., et al.
Publicado: (2016)

Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer
por: Ryu, Ho Hyun, et al.
Publicado: (2021)

SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues
por: Poola, Indira, et al.
Publicado: (2007)

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)

Structural Plasticity of Dendritic Spines Requires GSK3α and GSK3β
por: Cymerman, Iwona A., et al.
Publicado: (2015)

GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation
por: Gozdz, Agata, et al.
Publicado: (2017)

Human estrogen receptor-α (ER-α) transactivation by selective estrogen receptor modulators (SERMs) on VIT regulatory region in ER-α-negative breast cancer cell line Evsa-T transiently transfected by ER-α
por: Nyamagana Butera, IP, et al.
Publicado: (2001)

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
por: Reese, Jordan M, et al.
Publicado: (2014)

Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer
por: Alhammad, Rashed
Publicado: (2022)

Opposing Roles of GSK3α and GSK3β Phosphorylation in Platelet Function and Thrombosis
por: Moore, Samantha F., et al.
Publicado: (2021)

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
por: Bronte, Giuseppe, et al.
Publicado: (2019)

Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells
por: Li, Yuanyuan, et al.
Publicado: (2010)

A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells
por: Kala, Rishabh, et al.
Publicado: (2016)

ECM1 is associated with endocrine resistance in ER(+) breast cancers
por: Lee, Tae Won, et al.
Publicado: (2022)

AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
por: Rangel, Nelson, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t416bmp5pj95uvhcoceees6904